Tickers

1. Composite Trajectory Verdict

Given GNRC's capital-intensive manufacturing model, significant debt obligations, and cyclical demand exposed to power outage activity, all three statements carry roughly equal weight: the income statement reveals operating leverage and margin dynamics, the cash flow statement shows conversion quality and funding capacity for capex/debt/service, and the balance sheet reflects leverage, liquidity, and inventory risk.

Composite Trajectory: Deteriorating

The annual income statement shows a sharp reversal: net sales declined 2.0% to $4.21B while operating income fell 46.1% to $289M and net income attributable to Generac dropped 49.6% to $159.6M (10-K 2025, Consolidated Statements of Operations). Operating cash flow declined 40.9% to $438M despite lower cash tax payments, driven by a significant reduction in net working capital benefit that did not repeat and lower operating earnings (10-K 2025, Consolidated Statements of Cash Flows). The balance sheet remains solid with total leverage of 1.39x and interest coverage of 11.76x (10-K 2025, MD&A), but inventory rose 21% to $1.25B against falling sales and other accrued liabilities nearly doubled to $591M, largely from legal accruals (10-K 2025, Consolidated Balance Sheets; Note 8). The earnings and cash flow deterioration outweighs the stable leverage profile.

2. Red Flags

• Legal provisions surge: Operating expenses included $142.3M for legal provisions, settlements, patent costs and other legal matters in 2025 versus $10.5M in 2024, driving a 48.1% jump in G&A and a 17.2% rise in total operating expenses (10-K 2025, MD&A).
• GAAP-to-adjusted earnings gap widening: GAAP net income attributable to Generac was $159.6M while non-GAAP Adjusted Net Income was $376.0M in 2025; in 2024 the gap was $316.3M vs $438.5M (10-K 2025, Non-GAAP Measures).
• Operating cash flow collapse: Net cash from operations fell 40.9% YoY to $438M; the decline was driven by the absence of a prior-year working capital release and lower operating earnings (10-K 2025, Consolidated Statements of Cash Flows).
• Inventory buildup amid sales decline: Inventories increased 21% to $1.25B while net sales fell 2.0%; finished goods rose to $531M from $413M (10-K 2025, Consolidated Balance Sheets; Note 8).
• Accrued legal liabilities spike: Other accrued liabilities jumped to $591M from $313M, including $248M for accrued legal & professional fees (10-K 2025, Note 8).
• Goodwill sensitivity in Clean Energy: The Clean Energy reporting unit's fair value exceeded carrying value by only ~20% as of Oct 31, 2025; a 100 bps discount rate increase or 210 bps growth rate reduction would bring fair value to carrying value (10-K 2025, Critical Accounting Policies).
• Wallbox investment losses: Non-cash losses from fair value changes in Wallbox warrants and equity securities were $20.6M in 2025 and $38.0M in 2024 (10-K 2025, Consolidated Statements of Operations; Note 5).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue declined 2.0% to $4.21B in 2025 from $4.30B in 2024, with residential products down 6.8% to $2.27B offset by C&I growth of 4.9% to $1.46B (10-K 2025, Consolidated Statements of Operations). Gross margin compressed 50 bps to 38.3% due to higher input costs, unfavorable mix, and an inventory provision (10-K 2025, MD&A). Operating expenses surged 17.2% to $1.32B, driven by $142.3M in legal provisions versus $10.5M a year earlier (10-K 2025, MD&A). Operating income fell 46.1% to $289M (6.9% margin vs 12.5%), and net income attributable to Generac dropped 49.6% to $159.6M (10-K 2025, Consolidated Statements of Operations). Diluted EPS fell to $2.69 from $5.39 (10-K 2025, Consolidated Statements of Comprehensive Income). The three-year annual series (2023–2025) shows a peak in 2024 followed by a sharp reversal in 2025.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Net cash provided by operating activities declined 40.9% to $438M in 2025 from $741M in 2024, primarily due to the non-recurrence of a significant net working capital reduction in the prior year and lower operating earnings, partially offset by lower cash tax payments (10-K 2025, Consolidated Statements of Cash Flows). Capital expenditures rose to $170M from $137M, pushing free cash flow (operating cash flow minus capex) down to roughly $268M from $605M (10-K 2025, Consolidated Statements of Cash Flows; MD&A). Investing cash outflows moderated to $173M from $209M as acquisition spending slowed (10-K 2025, Consolidated Statements of Cash Flows). Financing cash outflows narrowed to $213M from $449M, reflecting lower debt repayments ($217M vs $850M) and similar share repurchases ($148M vs $153M) (10-K 2025, Consolidated Statements of Cash Flows). The operating cash flow decline is the dominant negative signal.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Stable

Total assets grew 9.1% to $5.57B from $5.11B, funded by a 12.3% rise in total liabilities to $2.93B and a 5.6% increase in total equity to $2.64B (10-K 2025, Consolidated Balance Sheets). Cash increased 21% to $341M. Total debt (short-term borrowings plus long-term borrowings and finance lease obligations) rose modestly to $1.31B from $1.27B (10-K 2025, Consolidated Balance Sheets; Note 12). Leverage metrics remain comfortable: net secured leverage ratio 1.32x (covenant <3.75x), total leverage ratio 1.39x (covenant <3.75x), interest coverage 11.76x (covenant >3.00x) (10-K 2025, MD&A; Note 12). However, inventories jumped 21% to $1.25B and other accrued liabilities nearly doubled to $591M (largely legal accruals), warranting monitoring (10-K 2025, Consolidated Balance Sheets; Note 8). The redeemable noncontrolling interest of $0.7M reflects a new JV in Bahrain (10-K 2025, Note 4).

6. Data Gaps

• Quarterly GAAP income statement, cash flow, and balance sheet data for 2026 Q1, 2026 Q2, 2025 Q2, and 2025 Q3 (the 10-Q filings were listed but their contents were not provided in the document set).
• Full 2023 balance sheet details (inventories, accounts receivable, accounts payable, debt breakdown) for three-year trend comparison.
• Segment-level quarterly revenue and Adjusted EBITDA to assess intra-year dynamics.
• Forward-looking guidance or quantitative outlook for 2026 from management commentary.
• Detailed breakdown of the $142.3M legal provisions by matter to assess recurrence risk.